KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
16.60
-0.40 (-2.35%)
At close: Mar 23, 2026, 4:00 PM EDT
16.60
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:51 PM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $839.07 million as of March 23, 2026. Its market cap has increased by 41.73% in one year.
Market Cap
839.07M
Enterprise Value
794.66M
1-Year Change
41.73%
Ranking
Category
Stock Price
$16.60
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $839.07M, an increase of 548.93%. That is a compound annual growth rate of 18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 859.30M | 5.27% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
| Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 891.06M |
| Inhibrx Biosciences | 889.86M |
| Xencor | 889.60M |
| Phathom Pharmaceuticals | 883.33M |
| GH Research | 866.55M |
| SpyGlass Pharma | 866.25M |
| UroGen Pharma | 857.78M |
| Janux Therapeutics | 855.29M |